Terms ending in 2028
Every in-force patent on Merck Sharp and Dohme LLC's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,910,596 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,183,228 | Anticoagulant Antithrombotic Dual Inhibitors Comprising a Biotin Label In force · Medium confidence | Merck Sharp & Dohme B.V. | In force | Medium confidence | |
| US 7,775,056 | Intelligent Refrigerator for Storing Pharmaceutical Product Containers In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,879,839 | Potassium Channel Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,629,338 | Substituted Monocyclic CGRP Receptor Antagonists In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,732,187 | Recombinant Attenuated Clostridium Organisms and Vaccine In force · High confidence | Intervet Inc. | In force | High confidence | |
| US 7,592,348 | Heterocyclic Aspartyl Protease Inhibitors In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 8,852,632 | Pharmaceutical Formulation Containing a Release Rate Controlling Composition In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,879,875 | P38 Kinase Inhibiting Agents In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| US 7,678,905 | Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes In force · High confidence | Merck Sharp & Dohme LLC | In force | High confidence | |
| 89 more term ends in 2028 · Pro | |||||
10 of 99 patents shown. Soonest term end first, then patent number.
Pro members see all 99, including 41 expiring within the 18 months from Nov 17, 2026.
90 of these are in force and held by Merck Sharp and Dohme LLC.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.